NSETrading Window29 Jun 2026 · 29 Jun 2026, 10:19 am
Trading Window
Indo Us Biotech Limited · INDOUS
✦ AI Summary
Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
INDOUS_29062026101903_Closing_of_Trading_Window.pdf
View document text
Date: 29th June, 2026
BSE Limited National Stock Exchange of India Limited
Dept. of Corporate Services, Dept. of Corporate Compliances,
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block-G,
Dalal Street, Bandra Kurla Complex,
Mumbai- 400 001 Bandra (E) Mumbai- 400 051
BSE Scrip Code - 541304 NSE Symbol: INDOUS
Dear Sir/Madam,
Sub: Intimation of Closure of Trading Window
This is to inform you that in terms of Company’s Code of Conduct to Regulate, Monitor and Report
Trading by Designated Persons of the Company, pursuant to SEBI (Prohibition of Insider Trading)
Regulations 2015, as amended from time to time, read with BSE vide circular no. LIST/COMP/01/2019-
20 dated 2nd April, 2019, the Trading Window for dealing in the Securities of the Company will remain
closed from Wednesday, 1st July, 2026 till 48 hours after announcement / declaration of Unaudited
financial results for the quarter ended on 30th June, 2026.
This is for your information and record.
Thanking you,
Yours faithfully,
For, Indo Us Bio Tech Limited
Ms. Dimpy Joshi
Company Secretary & Compliance Officer